Advertisement

Journal of NeuroVirology

, Volume 25, Issue 4, pp 448–456 | Cite as

Infectious causes and outcomes in patients presenting with cerebral spinal fluid pleocytosis

  • Bethany L. Brown
  • Andrea Fidell
  • Gregory Ingolia
  • Eias Murad
  • J. David BeckhamEmail author
Article
  • 172 Downloads

Abstract

To evaluate the infectious etiologies, clinical features, and outcomes of patients with CNS infections at a tertiary care center. Patients that present with a pleocytosis in the cerebral spinal fluid (CSF), defined as a CSF WBC count > 5 cells/mm3, from July 2015 to June 2016 at a tertiary care hospital were analyzed for this report. Data from patients with confirmed (n = 43) and presumed (n = 51) CNS infections were analyzed. CNS infection was the leading known cause of CSF pleocytosis (n = 43, 18% of all patients with a pleocytosis in the CSF), and HSV-2 was identified as the leading causative pathogen (n = 10) followed by varicella zoster virus (n = 5). Fifty-three percent of patients with a pleocytosis in the CSF did not receive a diagnosis. In the patients that did not receive a diagnosis, CNS infection was presumed to be the cause in 51 patients (21% of patients with CSF pleocytosis). The mean time to diagnosis for patients with confirmed CNS infection was 16 days, but time to diagnosis was highly variable depending on the causative pathogen. There was a significant overlap in CSF parameters and peripheral white blood cell counts in patients diagnosed with a viral, bacterial, or fungal infection. Neuroimaging changes were present in only 44% of CNS infections. The overall mortality was 7% for CNS infections, and 17% of patients with a CNS infection had a severe neurologic deficit at presentation while only 3% had a severe deficit at the last neurologic assessment. This study provides new insights into the infectious causes of disease in a cohort of patients with pleocytosis in the CSF. The study provides new insights into the time to diagnosis and outcomes in patients that present with pleocytosis in the CSF.

Keywords

CSF pleocytosis CNS infection Encephalitis Meningitis 

Notes

Funding information

JDB is supported by grant funding VA Merit I01BX003863, DOD PRMRP PR160117 Medical Investigator-Initiated Research Award. BLB is supported in part by NIH/NCATS Colorado CTSI Grant Number UL1 TR001082.

Compliance with ethical standards

All work was reviewed and approved by the Colorado Multiple Institutional Review Board prior to data capture.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

13365_2019_739_MOESM1_ESM.docx (54 kb)
ESM 1 (DOCX 54 kb)

References

  1. Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF (2006) Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 34(11):2758–2765CrossRefPubMedGoogle Scholar
  2. Beckham JD, Tyler KL (2012) Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics 9(1):124–138CrossRefPubMedGoogle Scholar
  3. Boaretti M, Scalet G, Fontana R (2008) A two-year prospective study of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of viral infections of the central nervous system. New Microbiol 31(4):445–450PubMedGoogle Scholar
  4. Bodilsen J, Brandt CT, Sharew A, Dalager-Pedersen M, Benfield T, Schonheyder HC, Nielsen H (2018) Early versus late diagnosis in community-acquired bacterial meningitis: a retrospective cohort study. Clin Microbiol Infect 24(2):166–170CrossRefPubMedGoogle Scholar
  5. Brivet FG, Ducuing S, Jacobs F, Chary I, Pompier R, Prat D, Grigoriu BD, Nordmann P (2005) Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach. Intensive Care Med 31(12):1654–1660CrossRefPubMedGoogle Scholar
  6. Erdem H, Cag Y, Ozturk-Engin D, Defres S, Kaya S, Larsen L, Poljak M, Barsic B, Argemi X, Sorensen SM, Bohr AL, Tattevin P, Gunst JD, Bastakova L, Jereb M, Johansen IS, Karabay O, Pekok AU, Sipahi OR, Chehri M, Beraud G, Shehata G, Del Vecchio RF, Maresca M, Karsen H, Sengoz G, Sunbul M, Yilmaz G, Yilmaz H, Sharif-Yakan A, Kanj SS, Parlak E, Pehlivanoglu F, Korkmaz F, Komur S, Kose S, Ulug M, Bolukcu S, Coskuner SA, Ince N, Akkoyunlu Y, Halac G, Sahin-Horasan E, Tireli H, Kilicoglu G, Al-Mahdawi A, Nemli SA, Inan A, Senbayrak S, Stahl JP, Vahaboglu H (2015) Results of a multinational study suggest the need for rapid diagnosis and early antiviral treatment at the onset of herpetic meningoencephalitis. Antimicrob Agents Chemother 59(6):3084–3089CrossRefPubMedPubMedCentralGoogle Scholar
  7. Erdem H, Inan A, Guven E, Hargreaves S, Larsen L, Shehata G, Pernicova E, Khan E, Bastakova L, Namani S, Harxhi A, Roganovic T, Lakatos B, Uysal S, Sipahi OR, Crisan A, Miftode E, Stebel R, Jegorovic B, Feher Z, Jekkel C, Pandak N, Moravveji A, Yilmaz H, Khalifa A, Musabak U, Yilmaz S, Jouhar A, Oztoprak N, Argemi X, Baldeyrou M, Bellaud G, Moroti RV, Hasbun R, Salazar L, Tekin R, Canestri A, Calkic L, Pratico L, Yilmaz-Karadag F, Santos L, Pinto A, Kaptan F, Bossi P, Aron J, Duissenova A, Shopayeva G, Utaganov B, Grgic S, Ersoz G, Wu AK, Lung KC, Bruzsa A, Radic LB, Kahraman H, Momen-Heravi M, Kulzhanova S, Rigo F, Konkayeva M, Smagulova Z, Tang T, Chan P, Ahmetagic S, Porobic-Jahic H, Moradi F, Kaya S, Cag Y, Bohr A, Artuk C, Celik I, Amsilli M, Gul HC, Cascio A, Lanzafame M, Nassar M (2017) The burden and epidemiology of community-acquired central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis 36:1595–1611CrossRefPubMedGoogle Scholar
  8. Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ, California Encephalitis P (2003) In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 36(6):731–742CrossRefPubMedGoogle Scholar
  9. Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, Schuster FL, Christie LJ, Tureen JH (2006) Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43(12):1565–1577CrossRefPubMedGoogle Scholar
  10. Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R (2016) Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 44(3):337–345CrossRefPubMedGoogle Scholar
  11. Lancaster E (2016) The diagnosis and treatment of autoimmune Encephalitis. J Clin Neurol 12(1):1–13CrossRefPubMedGoogle Scholar
  12. Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson JK, Soliven NL, Carroll K, Miller JA, Dien Bard J, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac K (2016) Multicenter evaluation of the BioFire FilmArray meningitis encephalitis panel for the detection of cacteria, viruses and yeast in cerebrospinal fluid specimens. J Clin Microbiol 54:2251–2261CrossRefPubMedPubMedCentralGoogle Scholar
  13. Baunbæk Egelund G1, Ertner G, Langholz Kristensen K, Vestergaard Jensen A, Benfield TL, Brandt CT (2017) Cerebrospinal fluid pleocytosis in infectious and noninfectious central nervous system disease: A retrospective cohort study. Medicine (Baltimore). 96(18):e6686.  https://doi.org/10.1097/MD.0000000000006686
  14. Parikh V, Tucci V, Galwankar S (2012) Infections of the nervous system. Int J Crit Illn Inj Sci 2(2):82–97CrossRefPubMedPubMedCentralGoogle Scholar
  15. Somand D, Meurer W (2009) Central nervous system infections. Emerg Med Clin North Am 27(1):89–100 ixCrossRefPubMedGoogle Scholar
  16. Tang YW, Mitchell PS, Espy MJ, Smith TF, Persing DH (1999) Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol 37(7):2127–2136PubMedPubMedCentralGoogle Scholar
  17. Ziai WC, Lewin JJ 3rd (2008) Update in the diagnosis and management of central nervous system infections. Neurol Clin 26(2):427–468 viiiCrossRefPubMedGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2019

Authors and Affiliations

  1. 1.Clinical Science Graduate ProgramUniversity of Colorado Graduate SchoolAuroraUSA
  2. 2.Biostatistics & InformaticsColorado School of Public HealthAuroraUSA
  3. 3.Department of MedicineUniversity of Chicago School of MedicineChicagoUSA
  4. 4.Department of Medicine, Division of Infectious DiseasesUniversity of Colorado School of MedicineAuroraUSA
  5. 5.Veterans AdministrationEastern Colorado Health SystemDenverUSA
  6. 6.Department of Neurology, Division of Neuroimmunology and Neurological InfectionsUniversity of Colorado School of MedicineAuroraUSA

Personalised recommendations